Acute and Preventive Therapy for Migraine

January 20th 2021, 6:00pm


Key opinion leaders discuss the differences between acute and preventive treatment in migraine, clinical guidelines and treatment selections, and options for migraine management and prevention.

Dr Rigmor Jensen Considers the Future of Research on Medication Overuse Headache

January 20th 2021, 3:30pm


It will be very interesting to understand the mechanism of medication overuse headache, along with the effects antibodies have on the condition, said Rigmor Jensen, MD, professor of neurology at The University of Copenhagen and director of the Danish Headache Center.

Data Show Migraineurs Who Respond to Triptans More Likely to Respond to Erenumab

January 18th 2021, 9:30pm


Compared with triptan nonresponders, patients with migraine who report a response to at least 1 triptan have a higher likelihood of responding to treatment with erenumab, according to real-world data published in The Journal of Headache and Pain.

New 5-Year Data Highlight Erenumab’s Efficacy, Safety

January 12th 2021, 5:18pm


Erenumab treatment has been associated with reductions in migraine frequency and improvements in health-related quality of life that were maintained for at least 5 years, according to the results of an open-label treatment phase of a recent study.

What Are the Real-Life Effects of Erenumab Discontinuation?

January 11th 2021, 4:37pm


Data on patients with migraine who stopped erenumab treatment show that over half of patients had an early disease worsening while the remaining patients maintained their responder status during weeks 1 through 4 post treatment.

Dr Frank Porreca Talks Through the Challenges of Measuring Migraine Pain

January 6th 2021, 3:00pm


Pain is a subjective response with multiple features and components, said Frank Porreca, PhD, professor of pharmacology and anesthesiology at the University of Arizona and a member of the Department of Collaborative Research at Mayo Clinic in Arizona.

Study Compares Vertigo’s Effects on Patients With Vestibular Migraine, BPPV

January 4th 2021, 10:18pm


The emotional, functional and physical effects of vertigo on patients with vestibular migraine were shown to be more significant compared with the experiences of patients with benign paroxysmal positional vertigo (BPPV) in a recent study.

Review Explores Association Between Migraine and Patent Foramen Ovale

January 1st 2021, 5:00pm


A “dose-response” relationship may exist between migraine and patent foramen ovale (PFO), according to a review published in Frontiers in Neurology.

Dr Peter McAllister Explains the Economic Benefits of Migraine Prevention

December 29th 2020, 2:00pm


Migraine accounts for many billions of dollars in direct and indirect health care costs, said Peter McAllister, MD, a neurologist, board certified headache specialist, and medical director of the New England Institute for Neurology and Headache.

Top 5 Most-Read Migraine Stories of 2020

December 25th 2020, 2:00pm


Our most-popular articles relating to migraine in 2020 included new research on menstrual migraine and the efficacy of erenumab, a calcitonin gene-related peptide inhibitor, for migraine.